10.1038/s12276-022-00739-7 18 HuJ.LiuW.ZouY.JiaoC.ZhuJ.XuQ.et al (2024)
Available from: Laterre PF, Pickkers P, Marx G, Wittebole X, Meziani F, Dugernier T, et al
Some treatments, like Mounjaro, go a step further by targeting an additional hormone, GIP, making it a GLP-1/GIP receptor agonist
A strategy for fusion expression and preparation of functional glucagon-like peptide-1 (GLP-1) analogue by introducing an enterokinase cleavage site
The synthetic version was designed to replicate those regulatory effects in a stable, injectable form